BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10703614)

  • 1. Identification of an HLA-B7 serological variant and its characterization by sequencing based typing.
    Dunn PP; Carter V; Dunn A; Day S; Fuggle SV; Ross J; Cavanagh G
    Tissue Antigens; 2000 Jan; 55(1):71-3. PubMed ID: 10703614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel HLA-B*07 variant, B*07:269, by sequence-based typing in a Taiwanese bone marrow stem cell donor.
    Yang KL; Lin PY
    HLA; 2016 Oct; 88(4):198-9. PubMed ID: 27581230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a novel variant of HLA-B*07, HLA-B*07:249, in a Taiwanese unrelated hematopoietic stem cell donor.
    Yang KL; Hung JH; Lin PY
    Tissue Antigens; 2015 Oct; 86(4):298-9. PubMed ID: 26198648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HLA-B7-specific antibody in an HLA-B*07 positive patient explained by a nonexpressed allele (HLA-B*07:181N).
    Wenda S; Faé I; Fischer GF
    HLA; 2017 Jul; 90(1):32-35. PubMed ID: 28417556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two new HLA class I alleles recognised by PCR sequence-specific primer and sequencing based typing: B*3805 and Cw*0408.
    García-Sánchez F; Fernández-De-Velasco J; Lillo R; Alvarez-Doval A; Rodríguez MA; Aviles MJ; Balas A; Vicario JL
    Tissue Antigens; 2002 Jan; 59(1):47-8. PubMed ID: 11972879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HLB-B null allele (B*0808N) caused by a nucleotide deletion in exon 3, found in the family of a bone marrow transplant recipient.
    Carter V; Dunn PP; Cavanagh G; Day S; Ross J; Chapman C
    Tissue Antigens; 2000 Jan; 55(1):61-4. PubMed ID: 10703611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of typing results by serology and polymerase chain reaction with sequence-specific primers for HLA-Cw in 650 individuals.
    Mytilineos J; Christ U; Lempert M; Opelz G
    Tissue Antigens; 1997 Oct; 50(4):395-400. PubMed ID: 9349625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-based typing of HLA-B: the B7 cross-reacting group.
    Voorter CE; van der Vlies SA; van den Berg-Loonen EM
    Tissue Antigens; 2000 Oct; 56(4):356-62. PubMed ID: 11098936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small test of a sequence-based typing method: definition of the B*1520 allele.
    Domena JD; Little AM; Arnett KL; Adams EJ; Marsh SG; Parham P
    Tissue Antigens; 1994 Oct; 44(4):217-24. PubMed ID: 7871522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the novel HLA-B*07:02:73 allele by sequencing-based typing.
    Elsermans V; Visentin J; Top I; Varlet P; Labalette M
    HLA; 2019 Jul; 94(1):65-66. PubMed ID: 30950225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an HLA-B*07 allele variant (B*0740) in the Chinese Han population.
    Wang CY; Pan Q; Xue M; Miao KR; Fei XM; Zhou XY; Zhao X; Kukuruga D; Osowski L; Poore B; Beattie R; Shi WX; Zhang H
    Tissue Antigens; 2005 Aug; 66(2):148-50. PubMed ID: 16029438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP).
    Bunce M; Fanning GC; Welsh KI
    Tissue Antigens; 1995 Feb; 45(2):81-90. PubMed ID: 7792765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of the detection of HLA-A*0104N in a family: a PCR-SSP reaction for the allelic detection of HLA-A*0104N.
    Moses JH; Downes J; McClenahan W; Clow N; Kennedy C; Greville WD; Dunckley H
    Eur J Immunogenet; 1999 Dec; 26(6):423-5. PubMed ID: 10583464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel allele, B*15012, by polymerase chain reaction using sequence-specific primers (PCR-SSP) and sequence-based typing.
    Day S; van Dam M; Buckland E; Dunn PP; Ross J
    Tissue Antigens; 2000 Jan; 55(1):78-9. PubMed ID: 10703616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete nucleotide sequence of HLA-B*0703, a B7 variant (BPOT).
    Bergmans AM; Tijssen H; Lardy N; Reekers P
    Hum Immunol; 1993 Oct; 38(2):159-62. PubMed ID: 8106270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the null HLA-A2 allele, A*0232N.
    Bunce M; Procter J; Dunn PP; Day S; Ross J; Welsh KI
    Tissue Antigens; 2000 Jan; 55(1):31-6. PubMed ID: 10703605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-A typing: comparison between serology, the amplification refractory mutation system with polymerase chain reaction and sequencing.
    Pera C; Delfino L; Morabito A; Longo A; Johnston-Dow L; White CB; Colonna M; Ferrara GB
    Tissue Antigens; 1997 Oct; 50(4):372-9. PubMed ID: 9349622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new HLA-B*39 allele: HLA-B*3924.
    Cook JT; Day S; Dunn PP; Welsh KI; Bunce M
    Tissue Antigens; 2000 Aug; 56(2):178-9. PubMed ID: 11019922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the novel HLA-B*07:305 allele by sequencing-based typing.
    Guidicelli G; Elsermans V; Top I; Ralazamahaleo M; Visentin J
    HLA; 2018 Apr; 91(4):296-297. PubMed ID: 29381263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new HLA-B*08 variant, HLA-B*0804.
    Eberle M; Lorentzen DF; Iwanaga KK; Hennes LF; Watkins DI
    Tissue Antigens; 1997 Mar; 49(3 Pt 1):256-61. PubMed ID: 9098933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.